27.06.2022 20:27 | MXC | IN BRIEF: MGC's CimetrA shows promise beyond Covid applications | Alliance |
27.06.2022 07:00 | MXC | CimetrATM Pre-clinical Trial Progress Report | RNS |
24.06.2022 10:13 | MXC | IN BRIEF: MGC Pharma moves ahead with Covid-19 treatment in US | Alliance |
24.06.2022 07:00 | MXC | USA Market Update: CimetrA Clinical Trial Progress | RNS |
16.06.2022 13:43 | MXC | IN BRIEF: MGC Pharmaceuticals completes research study on brain cancer | Alliance |
16.06.2022 07:00 | MXC | Successful Glioblastoma Pre-clinical Trial Results | RNS |
10.06.2022 11:19 | MXC, SAR, MTPH | Midatech Chair Rolf Stahel retires; Stephen Parker named as successor | Alliance |
06.06.2022 15:44 | EZJ, TUNE, CORO | TRADING UPDATES: Avation extends easyJet lease; Abingdon wins deal | Alliance |
06.06.2022 07:00 | MXC | CogniCann© Phase II Clinical Trial Results | RNS |
27.05.2022 13:08 | MXC | Compliance Filing of UK subsidiary FY21 Accounts | Reach |
23.05.2022 10:43 | MXC | Application for Admission to Trading | RNS |
20.05.2022 07:00 | MXC | Academic Paper on Effect of ArtemiC™ Published | Reach |
18.05.2022 12:06 | MXC | Director/PDMR Shareholding | RNS |
10.05.2022 07:01 | MXC | CannEpil® Drug Delivery System Patent Approval | RNS |
09.05.2022 12:28 | MXC | Director/PDMR Shareholding | RNS |
06.05.2022 15:08 | MXC | Replacement: Director/PDMR Shareholding | RNS |
05.05.2022 11:10 | MXC | Director/PDMR Shareholding | RNS |
04.05.2022 15:47 | MXC | IN BRIEF: MGC Pharmaceuticals finds partner for Indian market launch | Alliance |
04.05.2022 07:00 | MXC | Partnership with HempStreet | Reach |
29.04.2022 16:41 | MXC | Second Price Monitoring Extn | RNS |
29.04.2022 16:35 | MXC | Price Monitoring Extension | RNS |
29.04.2022 10:03 | MXC | March Quarterly Activities Report and Cash Flow | RNS |
26.04.2022 15:51 | YGEN, UOG, MXC | EXECUTIVE CHANGES: Carnival promotes COO & UK chief Weinstein to CEO | Alliance |
26.04.2022 07:00 | MXC | Appointment of new Chief Financial Officer | RNS |
25.04.2022 11:08 | MXC | Application for Admission to Trading | RNS |
22.04.2022 15:17 | ZPHR, EOG, TUN | TRADING UPDATES: Itaconix fundraise; Graft Polymer, MGC in patent wins | Alliance |
21.04.2022 07:00 | MXC | CimetrA™ Patent Approved by European IP Office | RNS |
12.04.2022 08:36 | MXC | Performance Rights and Change of CFO | RNS |
07.04.2022 10:35 | MXC | Director/PDMR Shareholding | RNS |
06.04.2022 12:02 | MXC | Notification of ASX Market Announcement | RNS |
05.04.2022 20:45 | PRIM, ALS, CASP | TRADING UPDATES: Rambler ups production; SRT Marine anticipates loss | Alliance |
05.04.2022 07:00 | MXC | Distribution Partnership with Sciensus Rare | RNS |
10.03.2022 09:10 | MXC | Joint Company Secretary Retirement | RNS |
04.03.2022 16:36 | MXC | Director/PDMR Shareholding | RNS |
01.03.2022 18:09 | MXC, GETB, CLX | TRADING UPDATES: Strong recovery from Revolution Bars, Vitec | Alliance |
01.03.2022 11:53 | MXC | Prior Share Issues & Admission to Trading | RNS |
01.03.2022 07:00 | MXC | Interim Financial Report | RNS |
22.02.2022 14:18 | ATYM, MXC, HOC | DIRECTOR DEALINGS: Atalaya Mining execs sells GBP2.4 million in shares | Alliance |
22.02.2022 08:08 | MXC | Director/PDMR Shareholding | RNS |
16.02.2022 13:51 | MXC | Result of General Meeting | RNS |
16.02.2022 12:15 | MXC | Share Issues in 2021 | RNS |
10.02.2022 10:30 | MXC | Issue of New Shares Completed in 2021 | RNS |
03.02.2022 16:08 | MXC | IN BRIEF: MGC Pharmaceuticals consideration shares sold to cover tax | Alliance |
03.02.2022 10:42 | MXC | Director/PDMR Shareholding | RNS |
31.01.2022 11:06 | MXC | Second Price Monitoring Extn | RNS |
31.01.2022 11:01 | MXC | Price Monitoring Extension | RNS |
31.01.2022 08:22 | MXC | December Quarterly Activities Report and Cash Flow | RNS |
14.01.2022 09:00 | MXC | Dispatch of General Meeting Documents | RNS |
06.01.2022 07:00 | MXC | Import approval for ArtemiC Rescue in India | RNS |
20.12.2021 07:00 | MXC | Clinical Study on influence of ArtemiC Support® | RNS |
08.12.2021 09:15 | MXC | Issue of Shares | RNS |
06.12.2021 09:30 | MXC | Placing Settlement | RNS |
30.11.2021 07:00 | MXC | £5.5m Capital Raising Completed | RNS |
29.11.2021 10:06 | MXC | Director/PDMR Shareholding | RNS |
25.11.2021 07:00 | MXC | Result of AGM | RNS |
24.11.2021 09:00 | MXC | Completion of $1m ArtemiC order to Swiss PharmaCan | RNS |
24.11.2021 07:00 | MXC | Issue of Shares & Extension of Convertible Note | RNS |
24.11.2021 07:00 | MXC | Director/PDMR Shareholding | RNS |
22.11.2021 09:30 | MXC | Full Cash Deposit Recieved for US Order of CimetrA | RNS |
19.11.2021 08:31 | MXC | Annual General Meeting Webinar Information | RNS |
16.11.2021 11:31 | MXC | Release of Shares from Voluntary Escrow | RNS |
12.11.2021 09:30 | MXC | Notification of ASX Market Announcement | RNS |
02.11.2021 07:00 | MXC | Malta Production Facility Completion | RNS |
01.11.2021 07:00 | MXC | Approval For Global CimetrA™ Dose Finding Study | RNS |
26.10.2021 07:00 | MXC | September 2021 Quarterly Report & Cash Flow | RNS |
25.10.2021 13:49 | MXC | Dispatch of Annual General Meeting Documents | RNS |
12.10.2021 07:00 | MXC | CimetrATM Investor Presentation | Reach |
07.10.2021 09:18 | MXC | Director/PDMR Shareholding | RNS |
06.10.2021 07:08 | MXC | AMC USA Places a US$3M Purchase Order for CimetrA | RNS |
06.10.2021 07:00 | MXC | Company Presentation October 2021 | RNS |
04.10.2021 09:29 | MXC | Director/PDMR Shareholding | RNS |
30.09.2021 08:00 | MXC | Annual Financial Report | RNS |
29.09.2021 07:00 | MXC | AMC Holdings orders first 1000 units of CimetrA™ | RNS |
22.09.2021 08:36 | MXC | Notification of ASX Market Announcements | RNS |
20.09.2021 11:03 | MXC | Director/PDMR Shareholding | RNS |